Literature DB >> 19559123

Suspension-Vero cell cultures as a platform for viral vaccine production.

Cristian Paillet1, Guillermina Forno, Ricardo Kratje, Marina Etcheverrigaray.   

Abstract

Since Vero cells are currently considered as an acceptable cell substrate to produce a wide range of viruses, we developed a virus production platform using Vero cells adapted to grow in suspension in serum-free media. After adapting anchorage-dependent Vero cells to grow as a free-cell suspension, vesicular stomatitis virus, herpes simplex virus 1 and polio virus 1 production rates were evaluated in batch cultures using spinner flasks and perfused cultures in a bioreactor. The achieved results constitute valuable information for the development of a low-cost high-productivity process using a suspension culture of Vero cells to produce viral vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559123     DOI: 10.1016/j.vaccine.2009.06.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Generation and characterization of a potentially applicable Vero cell line constitutively expressing the Schmallenberg virus nucleocapsid protein.

Authors:  Yongning Zhang; Shaoqiang Wu; Shanshan Song; Jizhou Lv; Chunyan Feng; Xiangmei Lin
Journal:  Cytotechnology       Date:  2017-01-12       Impact factor: 2.058

2.  Transformation and Tumorigenicity Testing of Simian Cell Lines and Evaluation of Poliovirus Replication.

Authors:  Silvia Dotti; Tina Lombardo; Riccardo Villa; Andrea Cacciamali; Cinzia Zanotti; Nadia Andrea Andreani; Stefano Cinotti; Maura Ferrari
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

3.  Quantification of Ebola virus replication kinetics in vitro.

Authors:  Laura E Liao; Jonathan Carruthers; Sophie J Smither; Simon A Weller; Diane Williamson; Thomas R Laws; Isabel García-Dorival; Julian Hiscox; Benjamin P Holder; Catherine A A Beauchemin; Alan S Perelson; Martín López-García; Grant Lythe; John N Barr; Carmen Molina-París
Journal:  PLoS Comput Biol       Date:  2020-11-02       Impact factor: 4.475

4.  Optimization of VSV-ΔG-spike production process with the Ambr15 system for a SARS-COV-2 vaccine.

Authors:  Osnat Rosen; Avital Jayson; Michael Goldvaser; Eyal Dor; Arik Monash; Lilach Levin; Lilach Cherry; Edith Lupu; Niva Natan; Meni Girshengorn; Eyal Epstein
Journal:  Biotechnol Bioeng       Date:  2022-03-31       Impact factor: 4.395

5.  Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Authors:  Verena Lohr; Yvonne Genzel; Ingo Jordan; Dietmar Katinger; Stefan Mahr; Volker Sandig; Udo Reichl
Journal:  BMC Biotechnol       Date:  2012-10-30       Impact factor: 2.563

6.  Suspension culture of Vero cells for the production of adenovirus type 5.

Authors:  Deuk-Ki Lee; Jihye Park; Dong-Won Seo
Journal:  Clin Exp Vaccine Res       Date:  2020-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.